Skip to main content

Table 5 Single dose adults—antibodies (reciprocal dilution)—by time interval

From: Validation of a yellow fever vaccine model using data from primary vaccination in children and adults, re-vaccination and dose-response in adults and studies with immunocompromised individuals

Categorical time

Number of individuals

Average time (days)

GMT (reciprocal dilution)

PV (5–9 years)

23

2797 (2008–3285)

152

PV (> 10 years)

45

5021 (3650–5475)

100